CY 2017 Prescription Drug Plan Total Beneficiary Cost Methodology
Guidance for: This document serves as a follow up to the CY2017 Final Call Letter with the purpose of publishing the Part D Total Beneficiary Cost (TBC) to support transparency related to the year-over-year out-of-pocket beneficiary costs.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: December 01, 2016
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.